<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39359461</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2054-5703</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Royal Society open science</Title><ISOAbbreviation>R Soc Open Sci</ISOAbbreviation></Journal><ArticleTitle>Probability of early infection extinction depends linearly on the virus clearance rate.</ArticleTitle><Pagination><StartPage>240903</StartPage><MedlinePgn>240903</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">240903</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1098/rsos.240903</ELocationID><Abstract><AbstractText>We provide an <i>in silico</i> study of stochastic viral infection extinction from a pharmacokinetical viewpoint. Our work considers a non-specific antiviral drug that increases the virus clearance rate, and we investigate the effect of this drug on early infection extinction. Infection extinction data are generated by a hybrid multiscale framework that applies both continuous and discrete mathematical approaches. The central result of our paper is the observation, analysis and explanation of a linear relationship between the virus clearance rate and the probability of early infection extinction. The derivation behind this simple relationship is given by merging different mathematical toolboxes.</AbstractText><CopyrightInformation>© 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Juhász</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Laboratory for Health Security, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bolyai Institute, University of Szeged, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartha</LastName><ForeName>F A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>National Laboratory for Health Security, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bolyai Institute, University of Szeged, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzban</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Integrated Mathematical Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Sciences, Zhejiang University of Science and Technology, Hangzhou, 310023, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Röst</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Laboratory for Health Security, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bolyai Institute, University of Szeged, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hungarian Centre of Excellence for Molecular Medicine (HCEMM), Szeged, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.c.7465773</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>R Soc Open Sci</MedlineTA><NlmUniqueID>101647528</NlmUniqueID><ISSNLinking>2054-5703</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">agent-based models</Keyword><Keyword MajorTopicYN="N">branching processes</Keyword><Keyword MajorTopicYN="N">multiscale mathematical modelling</Keyword><Keyword MajorTopicYN="N">spatially explicit model</Keyword><Keyword MajorTopicYN="N">stochastic extinction</Keyword></KeywordList><CoiStatement>We declare we have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39359461</ArticleId><ArticleId IdType="pmc">PMC11444767</ArticleId><ArticleId IdType="doi">10.1098/rsos.240903</ArticleId><ArticleId IdType="pii">rsos240903</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaidya NK, Bloomquist A, Perelson AS. 2021. Modeling within-host dynamics of SARS-cov-2 infection: a case study in ferrets. Viruses 13, 1635. (10.3390/v13081635)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081635</ArticleId><ArticleId IdType="pmc">PMC8402735</ArticleId><ArticleId IdType="pubmed">34452499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, et al. . 2021. A quantitative model used to compare within-host SARS-cov-2, MERS-cov, and SARS-cov dynamics provides insights into the pathogenesis and treatment of SARS-cov-2. PLoS Biol. 19, e3001128. (10.1371/journal.pbio.3001128)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001128</ArticleId><ArticleId IdType="pmc">PMC7984623</ArticleId><ArticleId IdType="pubmed">33750978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh I. 2021. Within host dynamics of SARS-cov-2 in humans: modeling immune responses and antiviral treatments. SN Comput. Sci. 2, 482. (10.1007/s42979-021-00919-8)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42979-021-00919-8</ArticleId><ArticleId IdType="pmc">PMC8506088</ArticleId><ArticleId IdType="pubmed">34661166</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack CP, Yan AWC, Brown JC, Sukhova K, Peacock TP, Barclay WS, Dorigatti I. 2023. Modelling the viral dynamics of the SARS-cov-2 delta and omicron variants in different cell types. J. R. Soc. Interface 20, 20230187. (10.1098/rsif.2023.0187)</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2023.0187</ArticleId><ArticleId IdType="pmc">PMC10410224</ArticleId><ArticleId IdType="pubmed">37553993</ArticleId></ArticleIdList></Reference><Reference><Citation>Song T, Wang Y, Gu X, Qiao S. 2023. Modeling the within-host dynamics of SARS-cov-2 infection based on antiviral treatment. Mathematics 11, 3485. (10.3390/math11163485)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/math11163485</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal A, Cardozo-Ojeda EF, Schiffer JT. 2020. Potency and timing of antiviral therapy as determinants of duration of SARS-cov-2 shedding and intensity of inflammatory response. Sci. Adv. 6, 10.(10.1126/sciadv.abc7112)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc7112</ArticleId><ArticleId IdType="pmc">PMC7679107</ArticleId><ArticleId IdType="pubmed">33097472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernhauerová V, Lisowski B, Rezelj VV, Vignuzzi M. 2021. Mathematical modelling of SARS-cov-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells. J. Theor. Biol. 531, 110895. (10.1016/j.jtbi.2021.110895)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2021.110895</ArticleId><ArticleId IdType="pmc">PMC8418984</ArticleId><ArticleId IdType="pubmed">34499915</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary MC, et al. . 2022. Emergence of SARS-cov-2 escape mutations during bamlanivimab therapy in a phase II randomized clinical trial. Nat. Microbiol. 7, 1906–1917. (10.1038/s41564-022-01254-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01254-1</ArticleId><ArticleId IdType="pmc">PMC9675946</ArticleId><ArticleId IdType="pubmed">36289399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari Gianlupi J, Mapder T, Sego TJ, Sluka JP, Quinney SK, Craig M, Stratford RE Jr, Glazier JA. 2022. Multiscale model of antiviral timing, potency, and heterogeneity effects on an epithelial tissue patch infected by SARS-cov-2. Viruses 14, 605. (10.3390/v14030605)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030605</ArticleId><ArticleId IdType="pmc">PMC8953050</ArticleId><ArticleId IdType="pubmed">35337012</ArticleId></ArticleIdList></Reference><Reference><Citation>Swat MH, Thomas GL, Belmonte JM, Shirinifard A, Hmeljak D, Glazier JA. 2012. Multi-scale modeling of tissues using CompuCell3D. Methods Cell Biol. 110, 325–366. (10.1016/B978-0-12-388403-9.00013-8)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-388403-9.00013-8</ArticleId><ArticleId IdType="pmc">PMC3612985</ArticleId><ArticleId IdType="pubmed">22482955</ArticleId></ArticleIdList></Reference><Reference><Citation>Getz M, et al. . 2021. Iterative community-driven development of a SARS-cov-2 tissue simulator. BioRxiv. (10.1101/2020.04.02.019075)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.02.019075</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuaib A, Motan D, Bhattacharya P, McNabb A, Skerry TM, Lacroix D. 2019. Heterogeneity in the mechanical properties of integrins determines mechanotransduction dynamics in bone osteoblasts. Sci. Rep. 9, 13113. (10.1038/s41598-019-47958-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47958-z</ArticleId><ArticleId IdType="pmc">PMC6739315</ArticleId><ArticleId IdType="pubmed">31511609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartha FA, Juhász N, Marzban S, Han R, Röst G. 2022. In silico evaluation of paxlovid’s pharmacometrics for SARS-cov-2: a multiscale approach. Viruses 14, 1103. (10.3390/v14051103)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051103</ArticleId><ArticleId IdType="pmc">PMC9146265</ArticleId><ArticleId IdType="pubmed">35632843</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzban S, Han R, Juhász N, Röst G. 2021. A hybrid PDE-ABM model for viral dynamics with application to SARS-cov-2 and influenza. R. Soc. Open Sci. 8, 210787. (10.1098/rsos.210787)</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.210787</ArticleId><ArticleId IdType="pmc">PMC8564626</ArticleId><ArticleId IdType="pubmed">34737874</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan WY, Wu H. 1998. Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies. Math. Biosci. 147, 173–205. (10.1016/s0025-5564(97)00094-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0025-5564(97)00094-1</ArticleId><ArticleId IdType="pubmed">9433062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamina A, Makuch RW, Zhao H. 2001. A stochastic modeling of early HIV-1 population dynamics. Math. Biosci. 170, 187–198. (10.1016/s0025-5564(00)00069-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0025-5564(00)00069-9</ArticleId><ArticleId IdType="pubmed">11292498</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffernan JM, Wahl LM. 2005. Monte Carlo estimates of natural variation in HIV infection. J. Theor. Biol. 236, 137–153. (10.1016/j.jtbi.2005.03.002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2005.03.002</ArticleId><ArticleId IdType="pubmed">16005307</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill SJ. 2005. The stochastic dance of early HIV infection. J. Comput. Appl. Math. 184, 242–257. (10.1016/j.cam.2003.09.057)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cam.2003.09.057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuckwell HC, Le Corfec E. 1998. A stochastic model for early HIV-1 population dynamics. J. Theor. Biol. 195, 451–463. (10.1006/jtbi.1998.0806)</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jtbi.1998.0806</ArticleId><ArticleId IdType="pubmed">9837702</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Corfec E, Tuckwell HC. 1998. Variability in early HIV-1 population dynamics. AIDS 12, 960–962.</Citation><ArticleIdList><ArticleId IdType="pubmed">9631156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson JE, Krapivsky P, Perelson AS. 2011. Stochastic theory of early viral infection: continuous versus burst production of virions. PLoS Comput. Biol. 7, e1001058. (10.1371/journal.pcbi.1001058)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1001058</ArticleId><ArticleId IdType="pmc">PMC3033366</ArticleId><ArticleId IdType="pubmed">21304934</ArticleId></ArticleIdList></Reference><Reference><Citation>Perelson AS, Ke R. 2021. Mechanistic modeling of SARS-cov-2 and other infectious diseases and the effects of therapeutics. Clin. Pharmacol. Ther. 109, 829–840. (10.1002/cpt.2160)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2160</ArticleId><ArticleId IdType="pmc">PMC8142935</ArticleId><ArticleId IdType="pubmed">33410134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-On YM, Flamholz A, Phillips R, Milo R. 2020. SARS-cov-2 (COVID-19) by the numbers. eLife 9, e57309. (10.7554/eLife.57309)</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57309</ArticleId><ArticleId IdType="pmc">PMC7224694</ArticleId><ArticleId IdType="pubmed">32228860</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcaterra M, Caruso C. 2021. Alveolar epithelial cell type II as main target of SARS-cov-2 virus and COVID-19 development via NF-kb pathway deregulation: a physio-pathological theory. Med. Hypotheses 146, 110412. (10.1016/j.mehy.2020.110412)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110412</ArticleId><ArticleId IdType="pmc">PMC7681037</ArticleId><ArticleId IdType="pubmed">33308936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason RJ. 2006. Biology of alveolar type II cells. Respirology 11, S12–S15. (10.1111/j.1440-1843.2006.00800.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2006.00800.x</ArticleId><ArticleId IdType="pubmed">16423262</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchemin C, Forrest S, Koster FT. 2006. Modeling influenza viral dynamics in tissue. In Artificial immune systems (eds Bersini H, Carneiro J), pp. 23–36. Berlin, Germany: Springer. (10.1007/11823940_3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/11823940_3</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord JS, Bonsall MB. 2021. The evolutionary dynamics of viruses: virion release strategies, time delays and fitness minima. Virus Evol. 7, veab039. (10.1093/ve/veab039)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab039</ArticleId><ArticleId IdType="pmc">PMC8242231</ArticleId><ArticleId IdType="pubmed">34221452</ArticleId></ArticleIdList></Reference><Reference><Citation>Perelson AS. 2002. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2, 28–36. (10.1038/nri700)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri700</ArticleId><ArticleId IdType="pubmed">11905835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Vargas EA, Velasco-Hernandez JX. 2020. In-host mathematical modelling of COVID-19 in humans. Annu. Rev. Control 50, 448–456. (10.1016/j.arcontrol.2020.09.006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcontrol.2020.09.006</ArticleId><ArticleId IdType="pmc">PMC7526677</ArticleId><ArticleId IdType="pubmed">33020692</ArticleId></ArticleIdList></Reference><Reference><Citation>
Juhász N, Bartha FA, Marzban S, Han R, Röst G. 2024. 
Supplementary codes for linearity of a drug response curve observed and explained in a hybrid model for SARS-CoV-2. See
https://github.com/msjuhasznora/linearity/releases/tag/linearity1.0.</Citation></Reference><Reference><Citation>Bravo RR, et al. . 2020. Hybrid Automata Library: a flexible platform for hybrid modeling with real-time visualization. PLoS Comput. Biol. 16, e1007635. (10.1371/journal.pcbi.1007635)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1007635</ArticleId><ArticleId IdType="pmc">PMC7105119</ArticleId><ArticleId IdType="pubmed">32155140</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wolfram Research . 2024. 
Mathematica, version 14.1. See
https://www.wolfram.com/mathematica.</Citation></Reference><Reference><Citation>Allen LJ. 2010. An introduction to stochastic processes with applications to biology. Boca Raton, FL: CRC Press.</Citation></Reference><Reference><Citation>Juhász N, Bartha FA, Marzban S, Han R, Röst G. 2024. msjuhasznora/linearity linearity1.0 (linearity1.0). Zenodo. (10.5281/zenodo.13345133)</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.13345133</ArticleId></ArticleIdList></Reference><Reference><Citation>Juhász N, Bartha FÁ, Marzban S, Han R, Röst G. 2024. Data from: Probability of early infection extinction depends linearly on the virus clearance rate. Figshare. (10.6084/m9.figshare.c.7465773)</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.c.7465773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>